Reliance Life Sciences (RLS), part of India's largest conglomerate, is expected to start phase I clinical studies of its indigenous Covid-19 vaccine soon. The Subject Expert Committee (SEC), which advises the drug regulator on vaccines and new drugs, reviewed the company’s application and is learnt to have recommended it for approval on Thursday.
from Times of India https://ift.tt/3kvvGN6
August 27, 2021 at 12:07AM
from Times of India https://ift.tt/3kvvGN6
August 27, 2021 at 12:07AM
Tags:
Times of India